Diebold Nixdorf Posts 19c Q3 EPS but Slashes Full-Year EBITDA and Cash Flow Outlook
DBD sits 24% above its 52-week low of $54.48.
Summary
Diebold Nixdorf earned 19 cents a share in the third quarter on revenue of $994.3 million, up 5% from a year ago, while adjusted EPS came in at $1.34. The top line held up, but the company cut its full-year adjusted EBITDA and free cash flow guidance — the part that matters for a leveraged hardware maker. Management also authorized a new $250 million buyback, which softens the blow but doesn't fix the cash flow problem. Q2 revenue was $930.8 million with EPS of $0.44 diluted, so the sequential profit step-down is steep. The guidance cut is the headline risk; watch whether the buyback is funded from cash or adds leverage.
At the time of this announcement, DBD was trading at $67.49 on NYSE in the Technology sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $54.48 to $92.09. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.